Evidence map›Paper›PMID 33838337›Full record

ArticleAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology2021

Outcome of trimethoprim-sulfamethoxazole challenge in previously reported patients with sulfa antibiotic allergy.

Hailey A Benesch, Vidya L Atluri, Bailey Healy, Lahari Rampur

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. How to Define and Manage Low-Risk Drug Allergy Labels.The journal of allergy and clinical immunology. In practice · 2024
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hailey A BeneschSchool of Medicine, University of Washington, Seattle, Washington.
Vidya L AtluriDivision of Allergy and Infectious Disease, Department of Medicine, University of Washington, Seattle, Washington. Electronic address: vlatluri@uw.edu.
Bailey HealySchool of Medicine, University of Washington, Seattle, Washington.
Lahari RampurDivision of Allergy and Infectious Disease, Department of Medicine, University of Washington, Seattle, Washington; Kaiser Permanente Washington, Seattle, Washington.

Funding

Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
HOST DEFENSE TRAINING IN ALLERGY AND INFECTIOUS DISEASEST32AI007044 · NIAID · UNIVERSITY OF WASHINGTON · PI DAVID Neal FREDRICKS · 1985 to 2026
$14.6M
NCCIH Supplement to NCATS/CTSA Program for KL2 Scholars - M. SoddersKL2TR002317 · NCATS · UNIVERSITY OF WASHINGTON · PI Christy Michelle McKinney · 2017 to 2026
$14.5M
NRSA Training CoreTL1TR002318 · NCATS · UNIVERSITY OF WASHINGTON · PI Megan Moore · 2017 to 2026
$8.4M
NCATS NIH HHS KL2 TR002317NCATS NIH HHS TL1 TR002318NCATS NIH HHS UL1 TR002319NIAID NIH HHS T32 AI007044
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Trimethoprim, Sulfamethoxazole Drug CombinationAdultAnti-Bacterial AgentsDrug CombinationsDrug HypersensitivityFemaleHumansMaleMiddle AgedSulfonamidesYoung AdultAnti-Bacterial AgentsDrug CombinationsSulfonamidesTrimethoprim, Sulfamethoxazole Drug Combination

Identifiers

PMID33838337
PMCPMC8627674

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.